Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06877884 · ClinicalTrials.gov registry record
A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
A clinical trial of Cancer, sponsored by N-Power Medicine.
- Recruiting
- Registry status
- 20,000
- Enrollment target
- 7
- Study locations
NCT06877884 is a study of Cancer that is actively recruiting participants, run by N-Power Medicine. The registered enrollment target is 20,000 participants, above the 3,459-participant average among 615 other Cancer trials with a reported enrollment target (478% higher). The trial reports 7 study locations across 6 states.
The verdict
NCT06877884, a study of Cancer, is actively recruiting participants, sponsored by N-Power Medicine.
- RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 7
- Study locations
Study Summary
This is an observational registry for patients at participating oncology centers. The data collection includes but is not limited to baseline variables, treatments given and outcome data. Patient surveys are also included. The aim of the study is to generate rich and standardized data for patients and to help enable more patients participate in clinical trials and contribute to research and development.
Conditions Studied
Study Locations (7)
Delaware
- Bayhealth Cancer Center-Kent - Dover
- Bayhealth Cancer Center- Sussex - Milford
California
- Pacific Cancer Care - Monterey
Illinois
- Northwest Oncology & Hematology - Elk Grove Village
New Mexico
- New Mexico Oncology Hematology Consultants - Albuquerque
Pennsylvania
- Lankenau Medical Center - Paoli
Texas
- Oncology Consultants, P.A. - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2099-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06877884
The ClinicalTrials.gov registry entry for NCT06877884 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,459-participant average among 615 other Cancer trials with a reported enrollment target (478% higher). The listed sponsor is N-Power Medicine, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT06877884 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Delaware, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT06877884 about?
NCT06877884 is a clinical study titled "A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data". This is an observational registry for patients at participating oncology centers. The data collection includes but is not limited to baseline variables, treatments given and outcome data. Patient surveys are also included. The aim of the study is to generate rich and standardized data for patients a...
What is the current status of trial NCT06877884?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2022-08-01. Estimated completion is 2099-01.
What conditions does trial NCT06877884 study?
This clinical trial studies the following conditions: Cancer.
Who is sponsoring clinical trial NCT06877884?
This trial is sponsored by N-Power Medicine, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06877884 being conducted?
This trial has 7 study locations across California, Delaware, Illinois, New Mexico, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.